SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001553350-23-000012
Filing Date
2023-01-05
Accepted
2023-01-05 17:14:27
Documents
20
Period of Report
2022-12-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT nhwk_8k.htm   iXBRL 8-K 30100
2 LEASE nhwk_ex10z1.htm EX-10.1 1589626
3 GRAPHIC image_003.jpg GRAPHIC 58298
4 GRAPHIC image_004.jpg GRAPHIC 22691
5 GRAPHIC image_007.gif GRAPHIC 19371
6 GRAPHIC image_012.gif GRAPHIC 76
7 GRAPHIC image_013.gif GRAPHIC 9227
8 GRAPHIC image_014.gif GRAPHIC 10151
  Complete submission text file 0001553350-23-000012.txt   2284997

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE nhwk-20221231.xsd EX-101.SCH 3739
10 XBRL DEFINITION FILE nhwk-20221231_def.xml EX-101.DEF 26569
11 XBRL LABEL FILE nhwk-20221231_lab.xml EX-101.LAB 36527
12 XBRL PRESENTATION FILE nhwk-20221231_pre.xml EX-101.PRE 25193
14 EXTRACTED XBRL INSTANCE DOCUMENT nhwk_8k_htm.xml XML 5277
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
NightHawk Biosciences, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 23512421
SIC: 2834 Pharmaceutical Preparations